KEGG   DRUG: Azathioprine
Entry
D00238                      Drug                                   
Name
Azathioprine (JP18/USP/INN);
Azasan (TN);
Imuran (TN);
Jayempi (TN)
Product
IMURAN (Sebela Pharmaceuticals)
  Generic
AZASAN (Salix Pharmaceuticals), AZATHIOPRINE (American Health Packaging), AZATHIOPRINE (Amneal Pharmaceuticals NY LLC), AZATHIOPRINE (Amneal Pharmaceuticals NY LLC), AZATHIOPRINE (Aphena Pharma Solutions - Tennessee), AZATHIOPRINE (Ascend Laboratories), AZATHIOPRINE (AvKARE), AZATHIOPRINE (AvKARE), AZATHIOPRINE (Glenmark Pharmaceuticals), AZATHIOPRINE (Golden State Medical Supply), AZATHIOPRINE (Oceanside Pharmaceuticals), AZATHIOPRINE (PD-Rx Pharmaceuticals), AZATHIOPRINE (REMEDYREPACK), AZATHIOPRINE (Rising Pharma Holdings), AZATHIOPRINE (Zydus Lifesciences Limited), AZATHIOPRINE (Zydus Lifesciences Limited), AZATHIOPRINE (Zydus Pharmaceuticals USA)
Formula
C9H7N7O2S
Exact mass
277.0382
Mol weight
277.27
Structure
Simcomp
Class
Anti-inflammatory
 DG01985  Disease modifying anti-rheumatic drug (DMARD)
Remark
Same as: C06837
Therapeutic category: 3999
ATC code: L04AX01
Chemical structure group: DG00743
Product (DG00743): D00238<JP/US> D03033<US>
Efficacy
Immunosuppressant, Nucleic acid biosynthesis inhibitor
  Disease
Prevention of rejection in renal homotransplantation [DS:H00083]
Rheumatoid arthritis [DS:H00630]
Comment
Azathioprine is metabolized to 6-mercaptopurine (6-MP) [DR:D04931]
Interaction
Structure map
map07046  Immunosuppressive agents
map07050  Antirheumatics - DMARDs and biological agents
Other map
map00983  Drug metabolism - other enzymes
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AX Other immunosuppressants
     L04AX01 Azathioprine
      D00238  Azathioprine (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Antimetabolites
   Azathioprine
    D00238  Azathioprine (JP18/USP/INN)
 Immunological Agents
  Immunosuppressants
   Antimetabolites, Purine
    Azathioprine
     D00238  Azathioprine (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D00238  Azathioprine (JP18/USP/INN)
Drug groups [BR:br08330]
 Anti-inflammatory
  DG01985  Disease modifying anti-rheumatic drug (DMARD)
   DG00743  Azathioprine
    D00238  Azathioprine
Drug classes [BR:br08332]
 Antirheumatic agent
  DG01985  Disease modifying anti-rheumatic drug (DMARD)
   D00238  Azathioprine
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00238  Azathioprine
  D00238  Azathioprine tablets
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D00238
Pharmacogenomic biomarkers [br08341.html]
 Polymorphisms and mutations affecting drug response
  D00238
Drug groups [BR:br08330]
 Anti-inflammatory
  DG01985  Disease modifying anti-rheumatic drug (DMARD)
   DG00743  Azathioprine
Other DBs
CAS: 446-86-6
PubChem: 7847305
ChEBI: 2948
LigandBox: D00238
NIKKAJI: J2.047H
LinkDB
KCF data

ATOM        19
            1   C8y C    22.2600  -23.0300
            2   C8y C    21.0700  -23.7300
            3   S2a S    22.2600  -21.6300
            4   N5x N    23.4500  -23.7300
            5   C8y C    21.0700  -25.1300
            6   N4x N    19.7400  -23.2400
            7   C8y C    21.0700  -20.9300
            8   C8x C    23.4500  -25.1300
            9   N5x N    19.7400  -25.5500
            10  N5x N    22.2600  -25.8300
            11  C8x C    18.9000  -24.4300
            12  C8y C    21.0700  -19.5300
            13  O3a O    23.5200  -19.5300 #-
            14  N2b N    22.2600  -18.8300 #+
            15  N5x N    19.7400  -19.1100
            16  C8x C    18.9000  -20.2300
            17  N4y N    19.7400  -21.3500
            18  O3a O    22.2600  -17.4300
            19  C1a C    18.5276  -22.0500
BOND        21
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 1
            10    6  11 1
            11    8  10 2
            12    9  11 2
            13    7  12 2
            14   13  14 1
            15   12  14 1
            16   12  15 1
            17   15  16 2
            18   16  17 1
            19    7  17 1
            20   14  18 2
            21   17  19 1

» Japanese version   » Back

KEGG   COMPOUND: C06837
Entry
C06837                      Compound                               
Name
Azathioprine
Formula
C9H7N7O2S
Exact mass
277.0382
Mol weight
277.27
Structure
Remark
Same as: D00238
Reaction
R08234
Pathway
map00983  Drug metabolism - other enzymes
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AX Other immunosuppressants
     L04AX01 Azathioprine
      D00238  Azathioprine (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Antimetabolites
   Azathioprine
    D00238  Azathioprine (JP18/USP/INN)
 Immunological Agents
  Immunosuppressants
   Antimetabolites, Purine
    Azathioprine
     D00238  Azathioprine (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D00238  Azathioprine (JP18/USP/INN)
Drug groups [BR:br08330]
 Anti-inflammatory
  DG01985  Disease modifying anti-rheumatic drug (DMARD)
   DG00743  Azathioprine
    D00238  Azathioprine
Drug classes [BR:br08332]
 Antirheumatic agent
  DG01985  Disease modifying anti-rheumatic drug (DMARD)
   D00238  Azathioprine
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00238  Azathioprine
  D00238  Azathioprine tablets
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D00238
Pharmacogenomic biomarkers [br08341.html]
 Polymorphisms and mutations affecting drug response
  D00238
Other DBs
CAS: 446-86-6
PubChem: 9055
ChEBI: 2948
NIKKAJI: J2.047H
LinkDB
KCF data

ATOM        19
            1   C8y C    23.5327  -23.0431
            2   C8y C    22.3420  -23.7435
            3   S2a S    23.5327  -21.6423
            4   N5x N    24.7234  -23.7435
            5   C8y C    22.3420  -25.1443
            6   N4x N    21.0112  -23.2532
            7   C8y C    22.3420  -20.9419
            8   C8x C    24.7234  -25.1443
            9   N5x N    21.0112  -25.5645
            10  N5x N    23.5327  -25.8447
            11  C8x C    20.1708  -24.4439
            12  C8y C    22.3420  -19.5411
            13  O3a O    24.7934  -19.5411 #-
            14  N2b N    23.5327  -18.8407 #+
            15  N5x N    21.0112  -19.1209
            16  C8x C    20.1708  -20.2415
            17  N4y N    21.0112  -21.3622
            18  O3a O    23.5327  -17.4399
            19  C1a C    19.7981  -22.0626
BOND        21
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 1
            10    6  11 1
            11    8  10 2
            12    9  11 2
            13    7  12 2
            14   13  14 1
            15   12  14 1
            16   12  15 1
            17   15  16 2
            18   16  17 1
            19    7  17 1
            20   14  18 2
            21   17  19 1

» Japanese version

DBGET integrated database retrieval system